Are you passionate about making a difference? Come meet us at our upcoming event and join our mission! Register Now



“My research concentrates on the discovery and demonstration of replicable high value care innovations – “medical home runs” that both lower total cost and improve care. Landmark’s approach to protecting patients in the most fragile states of health from costly and dangerous medical crises exemplifies the scalable translation of best available evidence on medical home runs.”

Dr. Milstein is Chairman of Landmark’s Clinical Advisory Board.

Dr. Milstein is a Professor of Medicine at Stanford University, and directs the Stanford Clinical Excellence Research Center, a collaboration of the Schools of Medicine, Engineering and Business.

Before joining Stanford’s faculty, Dr. Milstein’s career of applied research spanned private and public sector health care delivery and purchasing improvement. After launching a healthcare improvement firm (acquired by Mercer), he co-founded two public benefit initiatives, the Leapfrog Group and the Consumer-Purchaser Disclosure Project.

Dr. Milstein has also served on the faculty of UCSF’s Health Policy Institute and was appointed to a six year term as Congressional MedPAC Commissioner. Dr. Milstein has been selected for the highest award of both the National Business Group on Health (NBGH) and the American College on Medical Quality. He has been elected to the Institute of Medicine (IOM) of the National Academy of Sciences, where he chaired the planning committee on healthcare value improvement.

Dr. Milstein received his undergraduate education at Harvard College. He attended University of California at Berkeley, where he received his Master’s in Public Health, and received his M.D. from Tufts University.